Home › Funds › Millennium Management › NRIX
Millennium Management position in NRIX
NURIX THERAPEUTICS INC · Health Care
Latest position (Q2 2026)20.91K sh
Reported value held$507.28K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 236.88K | $7.10M | New |
| Q4 2021 | 596.29K | $17.26M | Add |
| Q1 2022 | 366.23K | $5.13M | Reduce |
| Q2 2022 | 811.93K | $10.29M | Add |
| Q3 2022 | 739.92K | $9.64M | Reduce |
| Q4 2022 | 547.34K | $6.01K | Reduce |
| Q1 2023 | 461.59K | $4.10K | Reduce |
| Q2 2023 | 644.41K | $6.44M | Add |
| Q3 2023 | 288.16K | $2.26M | Reduce |
| Q4 2023 | 377.59K | $3.90M | Add |
| Q1 2024 | 374.25K | $5.50M | Reduce |
| Q2 2024 | 599.62K | $12.51M | Add |
| Q3 2024 | 221.72K | $4.98M | Reduce |
| Q4 2024 | 424.14K | $7.99M | Add |
| Q1 2025 | 874.40K | $10.39M | Add |
| Q2 2025 | 927.56K | $10.56M | Add |
| Q3 2025 | 1.52M | $14.08M | Add |
| Q4 2025 | 179.76K | $3.41M | Reduce |
| Q1 2026 | 546.30K | $8.47M | Add |
| Q2 2026 | 20.91K | $507.28K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NRIX
- BlackRock Inc 8.77M sh · $212.77M · Q2 2026
- Fidelity Management & Research (FMR) 5.49M sh · $133.07M · Q2 2026
- Morgan Stanley 4.76M sh · $115.54M · Q2 2026
- Vanguard Group 5.95M sh · $112.86M · Q4 2025
- Geode Capital Management 2.54M sh · $61.57M · Q2 2026
- ARK Invest 1.79M sh · $43.50M · Q2 2026
- Capital World Investors 1.79M sh · $43.37M · Q2 2026
- Citadel Advisors 1.53M sh · $37.10M · Q2 2026
- UBS Group AG 917.12K sh · $22.25M · Q2 2026
- Northern Trust Corp 876.07K sh · $21.25M · Q2 2026
- Bank of America Corp 842.09K sh · $20.43M · Q2 2026
- Charles Schwab Investment Management 833.30K sh · $20.22M · Q2 2026